Cigna Group Advances Standardization of Electronic Prior Authorization
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 24 2026
0mins
Should l Buy CI?
Source: Newsfilter
- Standardization Commitment: The Cigna Group has joined leading health plans in a commitment to standardize electronic prior authorization submission requirements, expecting to cover over 70% of prior authorization volume by year-end, thereby accelerating patient access to care and simplifying administrative tasks for providers.
- Authorization Volume Reduction: Cigna has reduced the overall volume of medical prior authorizations by approximately 15%, making it easier for patients to access care while alleviating paperwork burdens for providers, which enhances the efficiency of healthcare delivery.
- Industry Collaboration Milestone: This initiative represents a significant milestone in the health plan industry's multi-year commitments made in partnership with HHS and CMS to streamline the prior authorization process and support the acceleration of real-time electronic approvals, further modernizing healthcare services.
- Enhanced Patient Experience: Cigna's Chief Medical Officer emphasized the company's goal of ensuring patients receive necessary care when needed while allowing doctors and teams to focus on patient care rather than paperwork, highlighting the company's ongoing commitment to improving healthcare experiences.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CI
Wall Street analysts forecast CI stock price to rise
16 Analyst Rating
14 Buy
2 Hold
0 Sell
Strong Buy
Current: 290.580
Low
300.00
Averages
335.63
High
378.00
Current: 290.580
Low
300.00
Averages
335.63
High
378.00
About CI
The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cigna Set to Announce Q1 Earnings with Strong Estimates
- Earnings Announcement: Cigna is set to release its Q1 earnings on April 30 before market open, with consensus EPS estimates at $7.61, reflecting a 12.9% year-over-year increase, which could bolster investor confidence in the company's profitability.
- Revenue Expectations: The anticipated revenue for Q1 stands at $66.2 billion, marking a 1.1% year-over-year growth; while modest, this indicates Cigna's stable performance in a competitive health insurance market, potentially attracting income-focused investors.
- Historical Performance: Over the past two years, Cigna has surpassed EPS estimates 88% of the time and revenue estimates 100% of the time, suggesting a strong track record that may enhance market confidence in its future performance.
- Estimate Revision Trends: In the last three months, EPS estimates have seen 15 upward revisions and 1 downward revision, while revenue estimates experienced 2 upward and 6 downward revisions, reflecting mixed market sentiment regarding the company's future profitability, which could influence investor decisions.
See More
Cigna Group Reports Strong Q1 2026 Earnings Performance
- Strong Financial Performance: Cigna Group reported total revenues of $68.5 billion and adjusted earnings per share of $7.79 in Q1 2026, reflecting a 16% year-over-year growth, indicating robust demand in the healthcare insurance market and effective cost control strategies.
- Upgraded Full-Year Outlook: The company raised its full-year 2026 adjusted EPS outlook to at least $30.35, with expectations that second-quarter adjusted EPS will account for approximately 25% of the full-year forecast, showcasing management's confidence in future performance.
- Strategic Adjustment Plans: Cigna plans to exit the individual exchange market by year-end and initiate a strategic review of eviCore, aimed at optimizing resource allocation and enhancing overall business efficiency to address medical cost pressures and market competition.
- Launch of New Service Model: The company introduced a rebate-free pharmacy service model called [Signature], with expectations that by the end of 2028, at least 50% of Evernorth Pharmacy Benefit Services members will transition to this new model, further enhancing customer experience and market competitiveness.
See More
Cigna Q1 Earnings Beat Expectations with Strong Revenue Growth
- Earnings Beat: Cigna reported a Q1 non-GAAP EPS of $7.79, exceeding expectations by $0.18, indicating a robust profitability trend that could enhance investor confidence.
- Significant Revenue Growth: The company achieved Q1 revenue of $68.52 billion, a 4.7% year-over-year increase, surpassing estimates by $2.32 billion, reflecting strong performance in the health insurance market and solidifying its market position.
- 2026 Financial Outlook: Cigna projects total revenue of $281.77 billion for FY26, with an EPS consensus of $30.33, demonstrating confidence in future growth that may attract more long-term investors.
- Adjusted Operating Income: Cigna anticipates adjusted income from operations of at least $30.35 per share, with pre-tax adjusted income for Evernorth and Cigna Healthcare projected at $6.9 billion and $4.525 billion respectively, showcasing robust growth potential across its business segments.
See More
Stocks Pull Back as Oil Prices Rise, Impacting Market Sentiment
- Rising Oil Prices: West Texas Intermediate crude surpassed $107 per barrel and Brent crude exceeded $119, leading to a rise in U.S. gasoline prices to nearly $4.23 per gallon, up from $4.18 on Tuesday, indicating heightened market concerns over inflation.
- Fed Policy Divergence: The Federal Reserve maintained interest rates at its latest meeting, but for the first time, four officials dissented, reflecting internal disagreements on future monetary policy, which could influence market expectations regarding interest rate movements.
- Boeing Stock Decline: Boeing shares fell after Airbus secured a $21.37 billion order for 102 A320neo jets from China Southern Airlines, highlighting increased competitive pressure on Boeing in the Chinese market, although there remains potential for significant future orders.
- Earnings Season Approaches: Major companies like Amazon, Alphabet, Meta, and Microsoft are set to report earnings, with market focus on their performance regarding AI demand, supply constraints, and capital expenditures, with expectations that the four will collectively spend at least $608 billion this year to maintain competitiveness in the AI sector.
See More
US Stocks Fluctuate Slightly, Tech Stocks Reach New All-Time Highs
- Tech Stock Surge: The S&P 500 and Nasdaq 100 indices rose by 0.12% and 0.01% respectively on Monday, reaching all-time highs, reflecting strong market optimism regarding AI infrastructure demand, which is expected to boost technology earnings.
- Oil Price Impact: WTI crude oil prices surged over 2%, exerting downward pressure on the market as President Trump canceled negotiations with Iran, raising inflation expectations that could affect the broader economic landscape.
- Rising Treasury Yields: The 10-year Treasury yield increased to 4.337% due to rising inflation expectations from higher oil prices, with markets anticipating the Fed will keep rates unchanged this week while awaiting further developments in oil prices and inflation.
- Health Insurance Stocks Rally: Health insurance stocks such as Centene, Elevance Health, and Humana all rose over 3% on Monday, providing support to the overall market and demonstrating resilience in the sector amid the current economic environment.
See More
Chaos Erupts at White House Correspondents' Dinner Amid Security Incident
- White House Chaos: An armed man charged a security checkpoint during the White House Correspondents' Dinner, prompting evacuation of President Trump and officials, which has drawn widespread condemnation and highlights increasing political violence in the U.S.
- Investigation Closure: The Justice Department has ended its criminal investigation into Fed Chair Jerome Powell, clearing the way for Trump's nominee Kevin Warsh, which could significantly influence future monetary policy decisions.
- Iran Negotiation Halt: Trump canceled plans to send U.S. representatives to Pakistan for ceasefire talks, resulting in Brent crude prices surpassing $106 per barrel, exerting downward pressure on stock futures amid faltering peace talks.
- Tesla AI Testing: Tesla is beta testing xAI's Grok chatbot for in-vehicle voice commands, aiming to enhance driver experience, but safety experts warn that such features could distract drivers and compromise road safety.
See More
Cigna Set to Announce Q1 Earnings with Strong Estimates
- Earnings Announcement: Cigna is set to release its Q1 earnings on April 30 before market open, with consensus EPS estimates at $7.61, reflecting a 12.9% year-over-year increase, which could bolster investor confidence in the company's profitability.
- Revenue Expectations: The anticipated revenue for Q1 stands at $66.2 billion, marking a 1.1% year-over-year growth; while modest, this indicates Cigna's stable performance in a competitive health insurance market, potentially attracting income-focused investors.
- Historical Performance: Over the past two years, Cigna has surpassed EPS estimates 88% of the time and revenue estimates 100% of the time, suggesting a strong track record that may enhance market confidence in its future performance.
- Estimate Revision Trends: In the last three months, EPS estimates have seen 15 upward revisions and 1 downward revision, while revenue estimates experienced 2 upward and 6 downward revisions, reflecting mixed market sentiment regarding the company's future profitability, which could influence investor decisions.
See More
Cigna Group Reports Strong Q1 2026 Earnings Performance
- Strong Financial Performance: Cigna Group reported total revenues of $68.5 billion and adjusted earnings per share of $7.79 in Q1 2026, reflecting a 16% year-over-year growth, indicating robust demand in the healthcare insurance market and effective cost control strategies.
- Upgraded Full-Year Outlook: The company raised its full-year 2026 adjusted EPS outlook to at least $30.35, with expectations that second-quarter adjusted EPS will account for approximately 25% of the full-year forecast, showcasing management's confidence in future performance.
- Strategic Adjustment Plans: Cigna plans to exit the individual exchange market by year-end and initiate a strategic review of eviCore, aimed at optimizing resource allocation and enhancing overall business efficiency to address medical cost pressures and market competition.
- Launch of New Service Model: The company introduced a rebate-free pharmacy service model called [Signature], with expectations that by the end of 2028, at least 50% of Evernorth Pharmacy Benefit Services members will transition to this new model, further enhancing customer experience and market competitiveness.
See More
Cigna Q1 Earnings Beat Expectations with Strong Revenue Growth
- Earnings Beat: Cigna reported a Q1 non-GAAP EPS of $7.79, exceeding expectations by $0.18, indicating a robust profitability trend that could enhance investor confidence.
- Significant Revenue Growth: The company achieved Q1 revenue of $68.52 billion, a 4.7% year-over-year increase, surpassing estimates by $2.32 billion, reflecting strong performance in the health insurance market and solidifying its market position.
- 2026 Financial Outlook: Cigna projects total revenue of $281.77 billion for FY26, with an EPS consensus of $30.33, demonstrating confidence in future growth that may attract more long-term investors.
- Adjusted Operating Income: Cigna anticipates adjusted income from operations of at least $30.35 per share, with pre-tax adjusted income for Evernorth and Cigna Healthcare projected at $6.9 billion and $4.525 billion respectively, showcasing robust growth potential across its business segments.
See More
Stocks Pull Back as Oil Prices Rise, Impacting Market Sentiment
- Rising Oil Prices: West Texas Intermediate crude surpassed $107 per barrel and Brent crude exceeded $119, leading to a rise in U.S. gasoline prices to nearly $4.23 per gallon, up from $4.18 on Tuesday, indicating heightened market concerns over inflation.
- Fed Policy Divergence: The Federal Reserve maintained interest rates at its latest meeting, but for the first time, four officials dissented, reflecting internal disagreements on future monetary policy, which could influence market expectations regarding interest rate movements.
- Boeing Stock Decline: Boeing shares fell after Airbus secured a $21.37 billion order for 102 A320neo jets from China Southern Airlines, highlighting increased competitive pressure on Boeing in the Chinese market, although there remains potential for significant future orders.
- Earnings Season Approaches: Major companies like Amazon, Alphabet, Meta, and Microsoft are set to report earnings, with market focus on their performance regarding AI demand, supply constraints, and capital expenditures, with expectations that the four will collectively spend at least $608 billion this year to maintain competitiveness in the AI sector.
See More
US Stocks Fluctuate Slightly, Tech Stocks Reach New All-Time Highs
- Tech Stock Surge: The S&P 500 and Nasdaq 100 indices rose by 0.12% and 0.01% respectively on Monday, reaching all-time highs, reflecting strong market optimism regarding AI infrastructure demand, which is expected to boost technology earnings.
- Oil Price Impact: WTI crude oil prices surged over 2%, exerting downward pressure on the market as President Trump canceled negotiations with Iran, raising inflation expectations that could affect the broader economic landscape.
- Rising Treasury Yields: The 10-year Treasury yield increased to 4.337% due to rising inflation expectations from higher oil prices, with markets anticipating the Fed will keep rates unchanged this week while awaiting further developments in oil prices and inflation.
- Health Insurance Stocks Rally: Health insurance stocks such as Centene, Elevance Health, and Humana all rose over 3% on Monday, providing support to the overall market and demonstrating resilience in the sector amid the current economic environment.
See More
Chaos Erupts at White House Correspondents' Dinner Amid Security Incident
- White House Chaos: An armed man charged a security checkpoint during the White House Correspondents' Dinner, prompting evacuation of President Trump and officials, which has drawn widespread condemnation and highlights increasing political violence in the U.S.
- Investigation Closure: The Justice Department has ended its criminal investigation into Fed Chair Jerome Powell, clearing the way for Trump's nominee Kevin Warsh, which could significantly influence future monetary policy decisions.
- Iran Negotiation Halt: Trump canceled plans to send U.S. representatives to Pakistan for ceasefire talks, resulting in Brent crude prices surpassing $106 per barrel, exerting downward pressure on stock futures amid faltering peace talks.
- Tesla AI Testing: Tesla is beta testing xAI's Grok chatbot for in-vehicle voice commands, aiming to enhance driver experience, but safety experts warn that such features could distract drivers and compromise road safety.
See More
